CD79A and selective IgA deficiency disease: Several studies demonstrated that in patients with innate IgA deficiency, the first-line strategy is represented by detection of deamidated gliadin peptide IgG antibodies, which have the same performance in the diagnosis of CD as IgA anti-tTG2.